跳至主要内容
临床试验/CTRI/2017/06/008802
CTRI/2017/06/008802尚未招募3 期

Effect of probiotics on level of inflammatory markers in patients of acute coronary syndrome - EPIC

R and D Department of NEXTGEN PHARMA0 个研究点目标入组 312 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
312

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • PATIENTS WITH ACUTE CORONARY SYNDROME

排除标准

  • Acute coronary syndrome patients who also will have the following conditions
  • 1.Atrial flutter,
  • 2.Atrial fibrillation,
  • 3.Bundle branch block(BBB)
  • 4.Dilated cardiomyopathy
  • 5.Valvular heart disease
  • 6.Malignancy
  • 7.Chronic inflammatory conditions like
  • a)Systemic lupus erythmatosis
  • b)Rheumatoid Arthritis
  • c)Ulcerative colitis
  • d)Ankylosing spondylitis and others affecting the study markers.

研究者

发起方
R and D Department of NEXTGEN PHARMA

相似试验